EP300 and diabetes mellitus: HDAC inhibition by NaB has been reported to mitigate diabetes-provoked oxidative damage in aortic endothelial cells by triggering Nrf2 activation through improving aryl hydrocarbon receptor (AHR) and p300 occupancy at the Nrf2 promoter [287].